Congruence Therapeutics, a pioneering biotechnology company focused on developing novel small molecule correctors, has successfully closed a significant $39.5 million…
Read More
Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets
The U.S. Food and Drug Administration (FDA) has granted approval for a higher-dose formulation of Novo Nordisk’s blockbuster weight-loss medication,…
Read More
Novartis Acquires Promising Breast Cancer Drug SNV4818 from Synnovation Therapeutics for Up to $3 Billion
Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…
Read More
Gilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies
The Netherlands faces significant challenges in ensuring timely patient access to life-changing advanced therapy medicinal products (ATMPs), a situation exacerbated…
Read More
Expert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges
Despite promising clinical outcomes from the first-ever gene therapy trial for Huntington’s Disease (HD), a leading expert involved in the…
Read More
Quintessence Biotech Unveils Groundbreaking Artificial Cell Technology to Revolutionize Cell and Gene Therapy Manufacturing
Quintessence Biotech has introduced a pioneering bio-separation tool, dubbed DACS (Dynamic Artificial Cell System), designed to significantly alleviate the manufacturing…
Read More
UK Government Overhauls Medicine Regulation to Accelerate Patient Access and Boost Life Sciences Sector
The United Kingdom is set to revolutionize its medicine regulation framework, a move poised to significantly expedite patient access to…
Read More
Navigating the Biotech Frontier: Investors Reveal Keys to Startup Success at Advanced Therapies Conference
The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read More
Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline
Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…
Read More
Meningitis B Vaccine Expansion Under Consideration Amidst Kent Outbreak
The United Kingdom’s Health Secretary, Wes Streeting, is reportedly considering expanding the national immunisation schedule to include the Meningitis B…
Read More
